| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
s (XXL
s), a Variant of Stimulatory G Protein
-Subunit (Gs
), Is a Distinct, Membrane-Anchored GNAS Product that Can Mimic Gs
Endocrine Unit (C.A., M.J.M., H.A.W.T., M.B.), Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114; Department of Endodontics (C.A.), Center for Dental Sciences, Gülhane School of Medicine, 06018 Ankara, Turkey; Departments of Neurology (N.A., N.W.K., A.D.) and Pathology (N.W.K.), Boston University School of Medicine, Boston, Massachusetts 02115; and Research and Development Service/Geriatric Research Education and Clinical Center (N.A., N.W.K., A.D.), Veterans Affairs Boston Healthcare System, Boston, Massachusetts 02130
Address all correspondence and requests for reprints to: Murat Bastepe, M.D., Ph.D., Endocrine Unit, Massachusetts General Hospital, 50 Blossom Street, Thier 10, Boston, Massachusetts 02114. E-mail: bastepe{at}helix.mgh.harvard.edu.
GNAS gives rise to multiple imprinted gene products, including the
-subunit of the stimulatory G protein (Gs
) and its variant XL
s. Based on genomic sequence, the translation of XL
s begins from the middle of a long open reading frame, suggesting the existence of an N-terminally extended variant termed extralarge XL
s (XXL
s). Although XXL
s, like Gs
and XL
s, would be affected by most disease-causing GNAS mutations, its authenticity and biological significance remained unknown. Here we identified a mouse cDNA clone that comprises the entire open reading frame encoding XXL
s. Whereas XXL
s mRNA was readily detected in mouse heart by RT-PCR, it appeared virtually absent in insulinoma-derived INS-1 cells. By Northern blots and RT-PCR, XXL
s mRNA was detected primarily in the mouse brain, cerebellum, and spleen. Immunohistochemistry using a specific anti-XXL
s antibody demonstrated XXL
s protein in multiple brain areas, including dorsal hippocampus and cortex. In transfected cells, full-length human XXL
s was localized to the plasma membrane and mediated isoproterenol- and cholera toxin-stimulated cAMP accumulation. XXL
s-R844H, which bears a mutation analogous to that in the constitutively active Gs
mutant Gs
-R201H (gsp oncogene), displayed elevated basal signaling. However, unlike Gs
-R201H, which mostly remains in the cytoplasm, both XXL
s-R844H and a constitutively active XL
s mutant localized to the plasma membrane. Hence, XXL
s is a distinct GNAS product and can mimic Gs
, but the constitutively active XXL
s and Gs
mutants differ from each other regarding subcellular targeting. Our findings suggest that XXL
s deficiency or hyperactivity may contribute to the pathogenesis of diseases caused by GNAS mutations.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |